| LCD ID Number back
to top |
| L1959 |
| |
| LCD Title back
to top |
| Percutaneous Vertebroplasty |
| |
| Contractor's Determination
Number back
to top |
| L1959 |
| |
| AMA CPT / ADA CDT Copyright
Statement back
to top |
| CPT codes, descriptions and other data
only are copyright 2006 American Medical Association (or such other
date of publication of CPT). All Rights Reserved. Applicable
FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT)
(including procedure codes, nomenclature, descriptors and other data
contained therein) is copyright by the American Dental Association.
© 2002, 2004 American Dental Association. All rights reserved.
Applicable FARS/DFARS apply. |
| |
| CMS National Coverage
Policy back
to top |
Title XVIII of the Social Security Act,
Section 1862 (a)(1)(A). This section excludes coverage of items or
services that are not reasonable and necessary for the diagnosis or
treatment of illness or injury or to improve the functioning of a
malformed body member.
Title XVIII of the Social Security
Act, Section 1862 (a)(7). This section prohibits Medicare payment
for any expenses on items and services incurred for routine physical
examinations.
Title XVIII of the Social Security Act, Section
1833 (e). This section prohibits Medicare payment for any claim that
lacks the necessary information to process the
claim. |
| |
| Primary Geographic Jurisdiction back
to top |
New Jersey Tennessee |
| |
| Secondary Geographic Jurisdiction back
to top |
Alaska Alabama Arkansas Arizona California Colorado Connecticut Florida Georgia Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Michigan Minnesota Missouri Mississippi North
Carolina North Dakota Nebraska New Jersey New
Mexico Nevada New
York Ohio Oklahoma Oregon Pennsylvania Rhode
Island South
Carolina Tennessee Texas Utah Virginia Vermont Washington Wisconsin West
Virginia Wyoming |
| |
| Oversight
Region back
to top |
| Region IV |
| |
| |
| Original Determination
Effective Date back
to top |
| For services performed on or after
09/29/2002 |
| |
| Original Determination
Ending Date back
to top |
| |
| |
| Revision Effective
Date back
to top |
| For services performed on or after
12/09/2005 |
| |
| Revision Ending
Date back
to top |
| |
| |
| Indications and Limitations
of Coverage and/or Medical Necessity back
to top |
Percutaneous vertebroplasty is a
therapeutic orthopedic procedure that involves injection of bone
cement into a thoracic or lumbar vertebral body for the relief of
pain and the strengthening of bone. This procedure is being used for
patients with lytic lesions due to bone metastases, aggressive
hemangiomas, multiple myeloma, and for patients who have medically
intractable debilitating pain resulting from osteoporotic vertebral
collapse.
The procedure is performed using x-ray guidance to
accurately inject a medical grade cement, polymethylmethacrylate
(PMMA), into a partially compressed vertebral body. The procedure is
performed under general anesthesia or conscious sedation with
additional local anesthesia and usually lasts from 1-2 hours, unless
the cement is injected into two or more vertebral bodies. The
patient must remain flat for about three hours following the
procedure.
|
The Least You Need to Know
Percutaneous vertebroplasty is
covered for the treatment intractable and debilitating
symptoms of thoracic and lumbar collapsed vertebrae.
Conservative treatment must have failed, other causes of pain
must be ruled out, and the vertebral body must retain at least
one third of its original height. It is not covered as a
prophylactic procedure for osteoporosis.
|
Indications
Percutaneous
vertebroplasty is considered appropriate treatment for patients with
vertebral lesions resulting from osteolytic metastasis, multiple
myeloma, hemangioma, or osteonecrotic osteoporotic compression
fractures if the following criteria have been met:
- Severe debilitating pain or loss of mobility that cannot be
relieved by two to four weeks of conservative medical therapy
(e.g., a period of immobilization such as restricted
activity/bracing and analgesia/scheduled narcotic).
- Other causes of pain, such as herniated intervertebral disk,
have been ruled out by computed tomography or magnetic resonance
imaging.
- The affected vertebra has not been extensively destroyed and
is at least one third of its original height.
Limitations
Patient selection is
critical because the treatment is specific for pain associated with
simple vertebral fracture and compression. This treatment should not
be utilized nor expected to be effective for the treatment of
degenerative disc disease, herniated disc, or compression of the
spinal cord or its associated nerve roots. Vertebral bodies must
retain a significant portion of their original height as identified
on standard x-rays if successful injection of the medical cement is
to be expected. A neurologic examination should not demonstrate any
evidence of nerve compression.
The decision to perform this
procedure should be multidisciplinary, taking into consideration the
local and general extent of the disease, the spinal level involved,
the severity of pain experienced by the patient, previous treatments
and their outcomes, as well as the patient's neurological condition,
general state of health and life expectancy.
Vertebroplasty
is contraindicated in:
- Patients with infection of the area
- Patients with coagulation disorders (due to the large diameter
of the needles used for injection).
- Patients with extensive vertebral destruction (relative
contraindication)
- Patients with neurological symptoms related to compression
(relative contraindication)
- Situations in which there is no surgical backup for emergency
decompression in the event a neurological deficit develops during
the injection of polymethylmethacrylate.
Vertebroplasty
is not covered in:
- Patients with significant vertebral collapse (i.e., vertebra
reduced to less than one-third its original height)
- Chronic back pain except when a specific vertebral collapse
has been identified as a source of the pain
- Patients undergoing a prophylactic procedure for osteoporosis
of the spine.
|
| |
| Coverage Topic back
to top |
Surgical
Services | |